Showing results (11-20 of 25) with videos related to
Sort By:
Pageof 3
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 12, 2020
Baldness and Risk of Prostate Cancer in the Health Professionals Follow-up StudySaud Khan, Joshua Caldwell, Kathryn M Wilson, et al.International Journal of Cancer|December 12, 2024
Etiology of prostate cancer with the TMPRSS2:ERG fusion: A systematic review of risk factorsColleen B McGrath, Alaina H Shreves, Megan R Shanahan, et al.European Urology|January 10, 2021
Insulinemic and Inflammatory Dietary Patterns and Risk of Prostate CancerBenjamin C Fu, Fred K Tabung, Claire H Pernar, et al.British Journal of Cancer|May 30, 2020
The association of diabetes with risk of prostate cancer defined by clinical and molecular featuresXiaoshuang Feng, Mingyang Song, Mark A Preston, et al.Metabolites|March 14, 2020
A Metabolomics Analysis of Adiposity and Advanced Prostate Cancer Risk in the Health Professionals Follow-Up StudyBarbra A Dickerman, Ericka M Ebot, Brian C Healy, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 7, 2022
5-Alpha Reductase Inhibitors and Prostate Cancer Mortality among Men with Regular Access to Screening and Health CareJane B Vaselkiv, Carl Ceraolo, Kathryn M Wilson, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 16, 2018
A Prospective Study of Aspirin Use and Prostate Cancer Risk by TMPRSS2:ERG StatusKonrad H Stopsack, Amparo G Gonzalez-Feliciano, Samuel F Peisch, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 25, 2021
Association of Prediagnostic Blood Metabolomics with Prostate Cancer Defined by ERG or PTEN Molecular SubtypesXiaoshuang Feng, Cindy Ke Zhou, Clary B Clish, et al.American Journal of Epidemiology|March 16, 2022
Validity and Relative Validity of Alternative Methods of Assessing Physical Activity in Epidemiologic Studies: Findings From the Men's Lifestyle Validation StudyClaire H Pernar, Andrea K Chomistek, Junaidah B Barnett, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 5, 2022
Racial Disparities in Prostate Cancer: Evaluation of Diet, Lifestyle, Family History, and Screening PatternsMegan Hansen, Nadine M Hamieh, Sarah C Markt, et al.Pageof 3